Sickle Cell Nephropathy

Berman, Leonard B.

doi:10.1001/jama.1974.03230350051035

Cited by 41 publications

(22 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This tumor was described in 1995 by Davis et al, 1 which considered it the seventh sickle cell nephropathy. The six sickle cell nephropathies previously described by Berman,4 in 1974, are gross hematuria, papillary necrosis, nephrotic syndrome, renal infarction, inability to concentrate the urine and pyelonephritis. All of them are to a certain extent related to the obstruction of blood vessels and tissue hypoxia resulting from red blood cell sickling.…”

Section: Discussionmentioning

confidence: 99%

Renal medullary carcinoma: report of seven cases from Brazil

et al. 2007

View full text Add to dashboard Cite

We report seven cases of renal medullary carcinoma collected from several institutions in Brazil. In spite of a relatively high incidence of sickle cell trait in Brazil, this is a rare tumor. All patients were males between the ages of 8 and 69 years (mean 22 years). From the collected information, the most frequent presenting symptoms were gross hematuria and flank or abdominal pain. The duration of symptoms ranged from 1 week to 5 months. Most of the tumors were poorly circumscribed arising centrally in the renal medulla. Size ranged from 4 to 12 cm (mean 7 cm) and hemorrhage and necrosis were common findings. All seven cases described showed sickled red blood cells in the tissue and six patients were confirmed to have sickle cell trait. All cases disclosed the characteristic reticular pattern consisting of tumor cell aggregates forming spaces of varied size, reminiscent of yolk sac testicular tumors of reticular type. Other findings included microcystic, tubular, trabecular, solid and adenoid-cystic patterns, rhabdoid-like cells and stromal desmoplasia. A peculiar feature was suppurative necrosis typically resembling microabscesses within epithelial aggregates. The medullary carcinoma of the 69-year-old patient was associated with a conventional clear cell carcinoma. To our knowledge, this association has not been previously reported and the patient is the oldest in the literature. The survival after diagnosis or admission ranged from 4 days to 9 months. The 8-year-old African-Brazilian patient with a circumscribed mass is alive and free of recurrence 8 years after diagnosis. This case raises the question whether a periodic search for renal medullary carcinoma in young patients who have known abnormalities of the hemoglobin gene and hematuria could result in an early diagnosis and a better survival. Modern Pathology (2007) 20, 914-920;

show abstract

Section: Discussionmentioning

confidence: 99%

Renal medullary carcinoma: report of seven cases from Brazil

et al. 2007

View full text Add to dashboard Cite

show abstract

“…Where race had been recorded, all patients were black and all had sickled erthrocytes on histological examination. On this basis the tumor, which was termed medullary carcinoma on morphologic grounds, was designated the seventh sickle cell nephropathy (the others being gross hematuria, papillary necrosis, nephrotic syndrome, renal infarction, inability to concentrate urine and pyelonephritis); 23 since the original study over 160 cases have been reported. [24][25][26][27][28][29][30][31][32][33] Patient age at diagnosis ranges from 5 to 69 years with a mean age of 19 years.…”

Section: Renal Medullary Carcinomamentioning

confidence: 99%

Uncommon and recently described renal carcinomas

2009

View full text Add to dashboard Cite

Major consensus conferences held over a decade ago laid the foundations for the current (2004) WHO classification of renal carcinoma. Clear cell, papillary and chromophobe carcinomas account for 85-90% carcinomas seen in routine practice. The remaining 10-15% of carcinomas consist of rare sporadic and hereditary tumors, some of which had been long recognized, but many of which only emerged as distinct entities in the decade leading up to the WHO publication. Collecting-duct carcinoma is a rare, often lethal form of carcinoma. Medullary carcinoma associated with sickle cell trait, has emerged as a distinctive tumor showing some overlapping features with upper tract urothelial carcinoma. Mucinous tubular and spindle-cell carcinoma and tubulocystic carcinoma were earlier considered as patterns of low-grade collecting-duct carcinoma, but are now recognized as separate tumor entities. Carcinomas associated with somatic translocations of TFE3 and TFEB comprise a significant proportion of pediatric renal carcinomas. Oncocytoid renal carcinomas in neuroblastoma survivors was recognized as a unique tumor category in the WHO classification. Renal carcinoma associated with end-stage renal disease is now recognized as having distinct morphological patterns and behavior. In addition there is a group of rare recently described carcinomas, including clear cell papillary carcinoma, oncocytic papillary renal cell carcinoma, follicular renal carcinoma and leiomyomatous renal cell carcinoma. It behooves the surgical pathologist to not only be capable of diagnosing the common forms of renal cancer, but also to be aware of the rare types of renal carcinoma, many of which have emerged in recent years.

show abstract

“…The patients usually presented with hematuria, abdominal pain, and weight loss. Davis et al 1 referred to this disease as the "seventh sickle cell nephropathy" as an addition to the description by Berman 14 of the six nephropathies seen in patients with sickle cell disease or trait: hematuria, papillary necrosis, nephritic syndrome, renal infarction, inability to concentrate urine, and pyelonephritis. These tumors were designated as renal medullary carcinomas due to their dominant medullary location.…”

Section: Discussionmentioning

confidence: 99%